Drug Information

Drug General Information
Drug ID
D02PAW
Former ID
DNCL002277
Drug Name
TLC-388
Indication Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] Phase 2 [534814]
Company
TLC Biopharmaceuticals
Structure
Download
2D MOL
Target and Pathway
Target(s) Toposisomerase-1 Target Info Inhibitor [534814]
NetPath Pathway IL2 Signaling Pathway
PANTHER Pathway DNA replication
Pathway Interaction Database Caspase Cascade in Apoptosis
WikiPathways Integrated Pancreatic Cancer Pathway
References
Ref 534814Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience. Oncology. 1999;56(1):1-12.
Ref 534814Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience. Oncology. 1999;56(1):1-12.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.